Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza A virus H1N1 vaccine - Seqirus

Next Previous
X
Search
Drug Profile

Influenza A virus H1N1 vaccine - Seqirus

Alternative Names: A(H1N1) influenza vaccine - Seqirus; A/H1N1-SOIV (swine flu) vaccine - Seqirus; A/H1N1v vaccines - Seqirus; Adjuvanted cell culture-based influenza A H1N1 (2009) monovalent vaccine (Celtura®) - Seqirus; Celtura; Fluvirin A(H1N1) monovalent vaccine - Seqirus; Fluvirin A/H1N1; Focetria; H1N1 pandemic influenza virus vaccine - Seqirus; MF59-eH1N1 - Seqirus; Monovalent A/H1N1 influenza vaccine - Seqirus; Swine flu vaccine - Seqirus; Swine-origin influenza A/H1N1 virus monovalent subunit vaccine - Seqirus

Latest Information Update: 02 Aug 2019

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novartis
  • Developer Seqirus
  • Class Influenza A virus H1N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza A virus H1N1 subtype

Most Recent Events

  • 09 Nov 2015 CSL’s influenza vaccine business started operating under the brand name Seqirus
  • 18 Jul 2011 US FDA approves Fluvirin® for the 2011-2012 influenza season in USA
  • 13 Jun 2011 Novartis completes a Phase-III trial in Influenza-A virus H1N1 subtype in Belgium, Germany and Switzerland (NCT00970177)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top